Effect of Virtual Reality Immersion on Patient's Anxiety During Pre-oxygenation Before General Anaesthesia

Last updated: February 7, 2025
Sponsor: Ente Ospedaliero Cantonale, Bellinzona
Overall Status: Active - Recruiting

Phase

N/A

Condition

Panic Disorders

Mood Disorders

Anxiety Disorders

Treatment

Virtual reality immersion

Clinical Study ID

NCT06823141
ID 2024-02157
  • Ages > 18
  • All Genders

Study Summary

The goal of this clinical trial is to learn if the use of virtual reality immersion during pre-oxygenation before general anesthesia could be feasible and beneficial for the patient. The main questions it aims to answer are:

Does virtual reality immersion during pre-oxygenation reduce patient's anxiety? Does it impact patient's and anaesthetist's comfort? Is this technique easy to implement?

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All non-ambulatory patients undergoing elective surgery or procedure under generalanaesthesia with intravenous induction

  • Minimal age of 18 year old

  • Able to give informed consent for the study as documented by signature

Exclusion

Exclusion Criteria:

  • Lacking capacity or ability to complete the consent form and/or questionnaire andinterview method and/or incapacity to respond to the required obligations linked tothe study protocol (assessed by the operator)

  • Known cognitive dysfunction, previous history of neurological/psychiatric diseaselike epilepsy

  • Depression or anxiety under treatment

  • Non-Italian speaking patients

  • Anticipated difficult airway management

  • Injuries to the head/face that would prohibit wearing headsets

  • Active nasal bleeding or occlusion, nasal abnormality or recent nasal trauma, recentnasal surgery, significant raised intracranial pressure and base of skull fractures

  • Any pre-operative premedication, including pharmacological premedication

  • Rapid sequence induction

  • Haemodynamic instability

  • Infectious skin conditions on the head/face

  • Undrained pneumothorax

  • Contact isolation due to bacteria and viruses

  • Symptoms of vertigo or motion sickness

  • Reduced visual or auditory acuity

  • BMI > 35 kg/m2

  • Pregnancy

  • Claustrophobia

  • Pre-existing hypoxemia (baseline oxygen saturation < 92% when breathing room air)

  • Need for an arterial line before general anaesthesia induction

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Virtual reality immersion
Phase:
Study Start date:
February 08, 2025
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • Istituto Cardiocentro

    Lugano, Ticino 6900
    Switzerland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.